Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Cordless drills are the first point of contact most people have with power tools and function as a gateway drug to the DIY way of life. Toolmakers know this all too well, which is largely why drills ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback